Firebrick Pharma Limited (AU:FRE)
ASX:FRE
Australian Market
Holding AU:FRE?
Track your performance easily

Firebrick Pharma Limited (FRE) Financial Statements

1 Followers

Firebrick Pharma Limited Financial Overview

Firebrick Pharma Limited's market cap is currently ―. The company's EPS TTM is AU$-0.006; its P/E ratio is -8.64; Firebrick Pharma Limited is scheduled to report earnings on February 7, 2025, and the estimated EPS forecast is AU$―. See an overview of income statement, balance sheet, and cash flow financials.
Jun 22
Income Statement-
Total RevenueAU$ 4.12K
Gross ProfitAU$ 4.12K
EBITAU$ -3.79M
EBITDAAU$ -3.79M
Net Income Common StockholdersAU$ -3.80M
Balance Sheet-
Cash, Cash Equivalents and Short-Term InvestmentsAU$ 7.14M
Total AssetsAU$ 8.73M
Total DebtAU$ 0.00
Net DebtAU$ -7.14M
Total LiabilitiesAU$ 450.10K
Stockholders EquityAU$ 8.28M
Cash Flow-
Free Cash FlowAU$ -4.23M
Operating Cash Flow-
Investing Cash FlowAU$ -32.54K
Financing Cash FlowAU$ 10.23M
Currency in AUD

Firebrick Pharma Limited Earnings and Revenue History

Firebrick Pharma Limited Debt to Assets

Firebrick Pharma Limited Cash Flow

Firebrick Pharma Limited Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis